Neoadjuvant chemoradiotherapy or chemotherapy for esophageal cancer: what is the current evidence?
- 30 October 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 32 (2)
- https://doi.org/10.1093/dote/doy100
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PS02.120: NEOADJUVANT CHEMOTHERAPY VERSUS NEOADJUVANT CHEMORADIOTHERAPY FOR CANCER OF THE OESOPHAGUS OR GASTRO-OESOPHAGEAL JUNCTION: LONG-TERM RESULTSDiseases of the Esophagus, 2018
- Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trialDiseases of the Esophagus, 2018
- Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched studyEuropean Journal of Cardio-Thoracic Surgery, 2017
- Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trialEuropean Journal of Cancer, 2017
- Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancerEuropean Journal of Cardio-Thoracic Surgery, 2016
- The Current Evidence in Support of Multimodal Treatment of Locally Advanced, Potentially Resectable Esophageal CancerDigestive Diseases, 2014
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialEuropean Journal of Cancer, 2011
- Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancerFuture Oncology, 2010
- Treatment of Esophageal Cancer Based on HistologyAmerican Journal of Clinical Oncology, 2009